Order Article Reprints

Delgado-Maldonado T, Navarrete-Carriola DV, Vázquez-Jiménez LK, Paz-González AD, Wan B, Franzblau S, Mohammed OM, Rodríguez-Páez L, Aguirre-Alvarado C, Alcántara-Farfán V, et al. Nifuroxazide and 4-Hydroxybenzhydrazone Derivatives as New Antiparasitic (Trypanosoma cruzi and Leishmania mexicana) and Anti-Mycobacterium tuberculosis Agents. Pharmaceutics. 2025; 17(5):621. https://doi.org/10.3390/pharmaceutics17050621

Delgado-Maldonado, Timoteo, Diana V. Navarrete-Carriola, Lenci K. Vázquez-Jiménez, Alma D. Paz-González, Baojie Wan, Scott Franzblau, Othman Mueen Mohammed, Lorena Rodríguez-Páez, Charmina Aguirre-Alvarado, Verónica Alcántara-Farfán, and et al. 2025. "Nifuroxazide and 4-Hydroxybenzhydrazone Derivatives as New Antiparasitic (Trypanosoma cruzi and Leishmania mexicana) and Anti-Mycobacterium tuberculosis Agents" Pharmaceutics 17, no. 5: 621. https://doi.org/10.3390/pharmaceutics17050621

Delgado-Maldonado, T., Navarrete-Carriola, D. V., Vázquez-Jiménez, L. K., Paz-González, A. D., Wan, B., Franzblau, S., Mohammed, O. M., Rodríguez-Páez, L., Aguirre-Alvarado, C., Alcántara-Farfán, V., Cordero-Martínez, J., Bandyopadhyay, D., Moreno-Rodríguez, A., & Rivera, G. (2025). Nifuroxazide and 4-Hydroxybenzhydrazone Derivatives as New Antiparasitic (Trypanosoma cruzi and Leishmania mexicana) and Anti-Mycobacterium tuberculosis Agents. Pharmaceutics, 17(5), 621. https://doi.org/10.3390/pharmaceutics17050621